4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-20-012542
President and CEO acquired 15,450 shares (option exercise)
- President and CEO gave up 5,343 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Culley Brian M · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-06-30 | Exercise or conversion : show line 1 in the form | +15,450 | $0.87 | $13,442 | 170,731 | D |
| 2020-06-30 | Shares withheld for taxes : show line 2 in the form | −5,343 | $0.87 | $4,648 | 165,388 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-30 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −15,450 | 123,600 | D |
Loading xslF345X03/ownership.xml…